Letter to the Editor/Response

Denira Imamovic¹, Nurija Bilalovic², Faruk Skenderi², Vanesa Beslagic³, Timur Ceric^{1

4}, Berisa Hasanbegovic⁴, Semir Beslija^{1

4}, Semir Vranic^{1

2

5}

Affiliations

¹ School of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
² Department of Pathology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
³ Department of Radiology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
⁴ Department of Oncology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
⁵ College of Medicine, Qatar University, Doha, Qatar.

Comment

Denira Imamovic et al. Breast J. 2019 May.

. 2019 May;25(3):569.

doi: 10.1111/tbj.13284. Epub 2019 Apr 13.

Denira Imamovic¹, Nurija Bilalovic², Faruk Skenderi², Vanesa Beslagic³, Timur Ceric^{1

4}, Berisa Hasanbegovic⁴, Semir Beslija^{1

4}, Semir Vranic^{1

2

5}

¹ School of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
² Department of Pathology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
³ Department of Radiology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
⁴ Department of Oncology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
⁵ College of Medicine, Qatar University, Doha, Qatar.

No abstract available

Comment on

A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience.
Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. Imamovic D, et al. Breast J. 2018 Nov;24(6):1105-1108. doi: 10.1111/tbj.13140. Epub 2018 Sep 21. Breast J. 2018. PMID: 30240079 No abstract available.
Neo-adjuvant treatment in invasive apocrine carcinoma of the breast.
Altundag K. Altundag K. Breast J. 2019 May;25(3):568. doi: 10.1111/tbj.13285. Epub 2019 Apr 13. Breast J. 2019. PMID: 30980572 No abstract available.